{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T02:55:43Z","timestamp":1792032943661,"version":"4.4.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T00:00:00Z","timestamp":1669161600000},"content-version":"vor","delay-in-days":2914,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Pfizer, Inc.","award":["GA8851MQ"],"award-info":[{"award-number":["GA8851MQ"]}]}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1111\/ajt.12963","type":"journal-article","created":{"date-parts":[[2014,11,6]],"date-time":"2014-11-06T12:18:14Z","timestamp":1415276294000},"page":"2758-2764","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":102,"title":["Randomized, Double-Blind Trial of Anidulafungin Versus Fluconazole for Prophylaxis of Invasive Fungal Infections in High-Risk Liver Transplant Recipients"],"prefix":"10.1016","volume":"14","author":[{"given":"D.J.","family":"Winston","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.P.","family":"Limaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Pelletier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Safdar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.I.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Meneses","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.W.","family":"Busuttil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/ajt.12963_bib1","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1399-3062.2010.00492.x","article-title":"Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients","volume":"12","author":"Neofytos","year":"2010","journal-title":"Transplant Infect Dis"},{"key":"10.1111\/ajt.12963_bib2","doi-asserted-by":"crossref","first-page":"729","DOI":"10.7326\/0003-4819-131-10-199911160-00003","article-title":"Prophylactic fluconazole in liver transplant recipients. A randomized, double-blind, placebo-controlled trial","volume":"131","author":"Winston","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1111\/ajt.12963_bib3","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1002\/lt.20690","article-title":"Antifungal prophylaxis in liver transplant patients: A systemic review and meta-analysis","volume":"12","author":"Cruciani","year":"2006","journal-title":"Liver Transplant"},{"issue":"Suppl 4","key":"10.1111\/ajt.12963_bib4","doi-asserted-by":"crossref","first-page":"S173","DOI":"10.1111\/j.1600-6143.2009.02909.x","article-title":"AST infectious diseases community of practice. Candida in solid organ transplant recipients","volume":"9","author":"Pappas","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.12963_bib5","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1086\/596757","article-title":"Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America","volume":"48","author":"Pappas","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1111\/ajt.12963_bib6","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/j.1600-6143.2007.02089.x","article-title":"Antifungal management practices in liver transplant recipients","volume":"8","author":"Singh","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.12963_bib7","doi-asserted-by":"crossref","first-page":"4922","DOI":"10.1128\/AAC.48.12.4922-4925.2004","article-title":"In vitro interactions between antifungal and immunosuppressants against Aspergillus fumigatus isolates from transplant and nontransplant patients","volume":"48","author":"Steinbach","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/ajt.12963_bib8","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1097\/TP.0b013e3181932e76","article-title":"Prophylaxis with caspofungin for invasive fungal infections in high-risk liver transplant recipients","volume":"87","author":"Fortun","year":"2009","journal-title":"Transplantation"},{"key":"10.1111\/ajt.12963_bib9","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/j.1399-0012.2004.00272.x","article-title":"Optimal prophylactic dosage and disposition of micafungin in living donor liver recipients","volume":"18","author":"Kishino","year":"2004","journal-title":"Clin Transplant"},{"key":"10.1111\/ajt.12963_bib10","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1097\/TP.0b013e31829d674f","article-title":"Micafungin versus amphotericin B lipid complex for the prevention of invasive fungal infections in high-risk liver transplant recipients","volume":"96","author":"Sun","year":"2013","journal-title":"Transplantation"},{"key":"10.1111\/ajt.12963_bib11","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1086\/505204","article-title":"Anidulafungin: A novel echinocandin","volume":"2","author":"Vazquez","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1111\/ajt.12963_bib12","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1093\/infdis\/170.3.644","article-title":"Risk factors for invasive fungal infections complicating orthotopic liver transplantation","volume":"170","author":"Collins","year":"1994","journal-title":"J Infect Dis"},{"key":"10.1111\/ajt.12963_bib13","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1097\/00007890-199610150-00010","article-title":"Risk factors of invasive Candida and non-Candida fungal infections after liver transplantation","volume":"62","author":"Patel","year":"1996","journal-title":"Transplantation"},{"key":"10.1111\/ajt.12963_bib14","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1053\/jlts.2002.36239","article-title":"Risk factors for invasive aspergillosis in liver transplant recipients","volume":"8","author":"Fortun","year":"2002","journal-title":"Liver Transpl"},{"key":"10.1111\/ajt.12963_bib15","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1086\/345441","article-title":"Trends in risk profiles for and mortality associated with invasive aspergillosis among liver transplant recipients","volume":"36","author":"Singh","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1111\/ajt.12963_bib16","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1399-0012.2010.01262.x","article-title":"Identifying a targeted population at high risk for infections after liver transplantation in the MELD era","volume":"25","author":"Sun","year":"2011","journal-title":"Clin Transplant"},{"key":"10.1111\/ajt.12963_bib17","doi-asserted-by":"crossref","first-page":"E454","DOI":"10.1111\/ctr.12129","article-title":"Fungal infections after liver transplantation: Outcomes and risk factors revisited in the MELD era","volume":"27","author":"Saliba","year":"2013","journal-title":"Clin Transplant"},{"key":"10.1111\/ajt.12963_bib18","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/myc.12041","article-title":"Pretransplant model for end stage liver disease score predicts posttransplant incidence of fungal infections after liver transplantation","volume":"56","author":"Lichtenstern","year":"2013","journal-title":"Mycoses"},{"key":"10.1111\/ajt.12963_bib19","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","volume":"46","author":"De Pauw","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1111\/ajt.12963_bib20","series-title":"Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard\u2014third edition. Document M27-A3.","year":"2008"},{"key":"10.1111\/ajt.12963_bib21","series-title":"Reference method for broth dilution antifungal susceptibility testing of filamentous fungi. Approved standard\u2014second edition. Document M38-A2.","year":"2008"},{"key":"10.1111\/ajt.12963_bib22","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1097\/00007890-200104150-00016","article-title":"Preemptive prophylaxis with a lipid preparation of amphotericin B for invasive fungal infections in liver transplant recipients requiring renal replacement therapy","volume":"71","author":"Singh","year":"2001","journal-title":"Transplantation"},{"key":"10.1111\/ajt.12963_bib23","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/jac\/dkg450","article-title":"Prevention of invasive fungal infections in liver transplant recipients: The role of prophylaxis with lipid formulations of amphotericin B in high-risk patients","volume":"52","author":"Fortun","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/ajt.12963_bib24","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/lt.20365","article-title":"Risk stratification and targeted antifungal prophylaxis for prevention of aspergillosis and other invasive mold infections after liver transplantation","volume":"11","author":"Hellinger","year":"2005","journal-title":"Liver Transplant"},{"key":"10.1111\/ajt.12963_bib25","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1086\/422312","article-title":"Micafungin versus fluconazole for prophylaxis against invasive fungal infections during neutropenia in patients undergoing hematopoietic stem cell transplantation","volume":"39","author":"Van Burik","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1111\/ajt.12963_bib26","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/j.bbmt.2012.03.014","article-title":"Multicenter, randomized, open-label study comparing the efficacy of micafungin versus itraconazole for prophylaxis of invasive fungal infections in patients undergoing hematopoietic stem cell transplant","volume":"18","author":"Huang","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1111\/ajt.12963_bib27","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1128\/AAC.50.1.143-147.2006","article-title":"Open-label randomized comparison of itraconazole versus caspofungin for prophylaxis in patients with hematologic malignancies","volume":"50","author":"Mattiuzzi","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/ajt.12963_bib28","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/SLA.0b013e3182a15db4","article-title":"The evolution of liver transplantation during 3 decades. Analysis of 5347 consecutive liver transplants at a single center","volume":"258","author":"Agopian","year":"2013","journal-title":"Ann Surg"},{"key":"10.1111\/ajt.12963_bib29","unstructured":"Stata, Version 13.1, College Station, TX."},{"key":"10.1111\/ajt.12963_bib30","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1002\/lt.21331","article-title":"Effect of prophylaxis on fungal infection and costs for high-risk liver transplant recipients","volume":"13","author":"Reed","year":"2007","journal-title":"Liver Transpl"},{"key":"10.1111\/ajt.12963_bib31","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1056\/NEJM199110313251803","article-title":"Increase in Candida krusei infections among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole","volume":"325","author":"Wingard","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1111\/ajt.12963_bib32","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1128\/AAC.37.9.1847","article-title":"Association of Torulopsis glabrata infections with fluconazole prophylaxis in neutropenic bone marrow transplant recipients","volume":"37","author":"Wingard","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/ajt.12963_bib33","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1093\/cid\/cit136","article-title":"Increasing echinocandin resistance in Candida glabrata: Clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations","volume":"56","author":"Alexander","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1111\/ajt.12963_bib34","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.bbmt.2009.06.019","article-title":"Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients. A global perspective","volume":"15","author":"Tomblyn","year":"2009","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fajt.12963","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fajt.12963","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522256986?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522256986?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/ajt.12963\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:08:18Z","timestamp":1761628098000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613522256986"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":34,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S1600613522256986"],"URL":"https:\/\/doi.org\/10.1111\/ajt.12963","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Randomized, Double-Blind Trial of Anidulafungin Versus Fluconazole for Prophylaxis of Invasive Fungal Infections in High-Risk Liver Transplant Recipients","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/ajt.12963","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}